Here we designed a nonhuman primate study to model HIV Env vaccination in the setting of maternal HIV infection and recent initiation of ART during the gestational period, and assessed the ability of vaccination to elicit potentially protective immune responses against the autologous, circulating virus. The gene discussed is ERVW-1; the disease is HIV infectious disease.